The role of albumin in critical illness

British Journal of Anaesthesia

Volumn 85, Issue 4, 2000, Pages 599-610

  Nicholson, J P ^a   Wolmarans, M R ^a   Park, G R ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Albumin; Literature review; Plasma proteins

Indexed keywords

ALBUMIN; BRADYKININ; CHLORPROPAMIDE; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; CYCLOSPORIN; DEXTRAN; DIAZEPAM; DIGITOXIN; ENDOTOXIN; FUROSEMIDE; HISTAMINE; INDOMETACIN; INTERLEUKIN 6; LEUKOTRIENE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MIDAZOLAM; PENICILLIN G; PHENYLBUTAZONE; PHENYTOIN; PLASMA PROTEIN; POLYGELINE; PROSTAGLANDIN; SALICYLIC ACID DERIVATIVE; SERUM ALBUMIN; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA; WARFARIN;

ACID BASE BALANCE; ANALBUMINEMIA; ANTICOAGULATION; ANTIOXIDANT ACTIVITY; BODY FLUID COMPARTMENT; BURN; CAPILLARY LEAK SYNDROME; CAPILLARY PERMEABILITY; CONTROLLED STUDY; CRITICAL ILLNESS; DRUG PROTEIN BINDING; EXTRAVASATION; GENE MUTATION; HUMAN; HYPOALBUMINEMIA; MYXEDEMA; ONCOTIC PRESSURE; PARACENTESIS; PLASMA HALF LIFE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW; SEPSIS; SURGICAL STRESS;

EID: 0033797981     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/85.4.599     Document Type: Review

References (110)

1. Protein binding of drugs in plasma from patients with acute renal failure
2. Comparison of nutritional indices and outcomes in critically ill patients
3. Endotoxin-induced arterial endothelial barrier dysfunction assessed by an in vitro model
4. Time to abandon routine albumin supplementation
5. Why albumin may work but still be bad for you
6. Serum albumin and colloid osmotic pressure in survivors and non-survivors of prolonged critical illness
7. The effects of albumin versus hydroxyethyl starch solution on cardiorespiratory and circulatory variables in critically ill patients
8. Influence of different volume therapies and pentoxifylline infusion on circulating soluble adhesion molecules in critically ill patients
9. Influence of different volume therapy regimens on regulators of the circulation in the critically ill
10. The pathogenesis of sepsis
11. Serum protein levels in critically ill surgical patients
12. Tumor necrosis factor-α inhibits albumin gene expression in a murine model of cachexia
13. Effect of albumin supplementation during parenteral nutrition on hospital morbidity
14. Structure of serum albumin
15. Acute-phase response of human hepatocytes: Regulation of acute-phase protein synthesis by interleukin-6
16. The outcome of surgical treatment as related to the response of the serum albumin level to nutritional support
17. Human albumin administration in critically ill patients: Systematic review of randomised controlled trials
18. Review: Albumin does not reduce death in critically ill patients with hypovolemia, burns, or hypoalbuminemia: Commentary
19. The binding of sulphonylureas to serum albumin
20. Differential effects of insulin deficiency on albumin and fibrinogen synthesis in humans
21. Meal stimulation of albumin synthesis: A significant contributor to whole body protein synthesis in humans
22. Effect of plasma and interstitial protein content on tissue oedema formation
23. Role of albumin in human physiology and pathophysiology
24. Use of albumin as a volume expander
25. Prolonged length of stay and reduced functional improvement rate in malnourished stroke rehabilitation patients
26. Increased vascular permeability: A major cause of hypoalbuminaemia in disease and injury
27. Synthesis of albumin by patients in septic shock
28. Albumin supplementation in the critically ill: A prospective randomised trial
29. Dynamics of blood and lymph flow
30. Randomised trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis
31. Pathogenesis and potential strategies for prevention and treatment of septic shock: An update
32. Association of serum albumin and mortality risk
33. Efficacy of albumin supplementation in the surgical intensive care unit: A prospective, randomised study
34. Albumin and the critically ill
35. Albumin abuse in intensive care medicine
36. Atomic structure and chemistry of human serum albumin
37. Albumin inhibits human polymorphonuclear leucocyte luminol-dependent chemiluminescence: Evidence for oxygen radical scavenging
38. Fluid volume and albumin kinetics occurring with major surgery
39. Antioxidant protection against hypochlorous acid in human plasma
40. Regulation of albumin synthesis by hormones and amino acids in primary cultures of rat hepatocytes
41. Newly synthesised RNA: Simultaneous measurement in intact cells of transcription rates and RNA stability of insulin-like growth-factor I, actin, and albumin in growth hormone-stimulated hepatocytes
42. Heparin like activity of albumin
43. On the inhibitory effect of albumin on platelet aggregation
44. Maintenance of adequate serum albumin during extended surgery seems beneficial
45. Review of the rapid normalisation of serum albumin with modified total parenteral nutrition solutions
46. Nitric oxide doseresponse study in the isolated perfused rat kidney after inhibition of endothelium-derived relaxing factor synthesis: The role of albumin
47. NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties
48. The myth of serum albumin as a marker of nutritional status
49. Albumin levels as a predictor of mortality in the elderly
50. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalised adults
51. Binding of drugs to serum albumin
52. Does reduced colloid oncotic pressure increase pulmonary dysfunction in sepsis?
53. Fixation of penicilloyl groups to albumin and appearance of anti-penicilloyl antibodies in penicillin-treated patients
54. Changes in plasma albumin concentration, synthesis rate and mRNA level during acute inflammation
55. Stimulation of albumin gene transcription by insulin in primary cultures of rat hepatocytes
56. Physiology and pathophysiology of colloid osmotic pressure and albumin metabolism
57. [Is albumin administration useful in critical care for burnt patients?]
58. Hypoproteinemic alkalosis
59. The prognostic value of serial measurements of serum albumin in patients admitted to an intensive care unit
60. 14
61. Why doesn't albumin work?
62. Eukaryotic protein synthesis
63. Reduction in colloid osmotic pressure associated with fatal progression of cardiopulmonary failure
64. Study of the molecular mechanism of decreased liver synthesis of albumin in inflammation
65. Turnover of human serum albumin before and after operations
66. Nutritional assessment of intensive-care unit patients
67. Glucocorticoid-dependent expression of the albumin gene in adult rat hepatocytes
68. Certain batches of albumin solutions influence the expression of endothelial cell adhesion molecules
69. The role of the urea cycle and polyamines in albumin synthesis
70. Effect of dextran infusions on protein synthesis by hepatic microsomes
71. Pathogenesis of human septic shock
72. Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression
73. Genetics: The albumin gene
74. Historical perspective
75. Ligand binding by albumin
76. Metabolism: Albumin in the body
77. The albumin molecule: Its structure and chemical properties
78. Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes
79. Lack of predictive value of the APACHE II score in hypoalbuminemic patients
80. Restoration effects of glucose refeeding on reduced synthesis of albumin and total protein on disaggregated polyribosomes in liver of starved rats: Evidence of post-transcriptional control mechanism
81. Incidence and mortality of hypoalbuminemic patients in hospitalised veterans
82. Midazolam induction time: Association with serum albumin
83. Alcohol, amino acids, and albumin synthesis
84. Extravascular albumin
85. Serum albumin
86. Low protein-high energy diet induces repressed transcription of albumin mRNA in rat liver
87. [Role of albumins in burnt patients: Its efficacy during intensive care. Addendum to the expert guidelines of the Consensus Conference, Paris, December 15th 1995]
88. Nonrespiratory predictor of mechanical ventilation dependency in intensive care unit patients
89. High affinity binding, endocytosis and degradation of conformationally modified albumins. Potential role of gp30 and gp18 as novel scavenger receptors
90. Specific albumin binding to microvascular endothelium in culture
91. Albondin-mediated capillary permeability to albumin. Differential role of receptors in endothelial transcytosis and endocytosis of native and modified albumins
92. The acute phase response of plasma protein synthesis during experimental inflammation
93. Serum albumin: A predictor of long-term outcome in peritoneal dialysis patients
94. Albumin kinetics in hypoalbuminaemic patients receiving total parenteral nutrition
95. Macrophage inflammatory protein-lamediates lung leukocyte recruitment, lung capillary leak, and early mortality in murine endotoxaemia
96. Colloid solutions in the critically ill. A randomised comparison of albumin and polygeline. 2. Serum albumin concentration and the incidences of pulmonary oedema and acute renal failure
97. Colloid solutions in the critically ill. A randomised comparison of albumin and polygeline. I. Outcome and duration of stay in the intensive care unit
98. The characterisation of two specific drug binding sites on human serum albumin
99. Physiological variables and fluid resuscitation in the postoperative intensive care unit patient
100. Relation between lowered colloid osmotic pressure, respiratory failure, and death
101. Crystalloid versus colloid: All colloids are not created equal
102. Human albumin administration in patients with liver dysfunction
103. Background and use
104. Which patients are most at risk of 'albumin toxicity' and why?
105. The antioxidant action of human extracellular fluids
106. Colloid oncotic pressure: Clinical significance
107. Oncotic pressure regulates gene transcriptions of albumin and apolipoprotein B in cultured rat hepatoma cells
108. Tissue sites of catabolism of albumin in rabbits
109. Lymph and pulmonary response to isobaric reduction in plasma oncotic pressure in baboons
110. Serum albumin is a specific inhibitor of apoptosis in human endothelial cells